Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Novaremed has raised €129M across 2 funding rounds from 1 investor, most recently a round in Jul 2022. Based in Basel, Switzerland; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2022-07-25 | Other | €127M | NeuroFront Therapeutics | View deal → |
| 2020-09-21 | Other | €2.3M | — | View deal → |
